GG

Gary J. Grover

ES E.R. Squibb & Sons.: 16 patents #30 of 513Top 6%
BS Bristol-Myers Squibb: 2 patents #1,811 of 3,969Top 50%
🗺 New Jersey: #4,597 of 69,400 inventorsTop 7%
Overall (All Time): #259,894 of 4,157,543Top 7%
18
Patents All Time

Issued Patents All Time

Showing 1–18 of 18 patents

Patent #TitleCo-InventorsDate
6916813 (1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase Karnail Atwal, Charles Z. Ding, Philip D. Stein, John Lloyd, Saleem Ahmad +3 more 2005-07-12
5679706 Combination of a potassium channel activator and an antiarrhythmic agent Albert J. D'Alonzo 1997-10-21
5643921 Cardiopulmonary bypass and organ transplant using a potassium channel activator 1997-07-01
5354764 Method for inhibiting myocardial cell necrosis and preserving heart function during myocardial ischemia and/or reperfusion Karnail Atwal 1994-10-11
5278169 Method of treating or prevention of fibrillation of the heart Karnail Atwal 1994-01-11
5256688 Method for inhibiting myocardial cell necrosis and preserving heart function during myocardial ischemia and/or reperfusion Karnail Atwal 1993-10-26
H1139 Combination of a calcium channel blocker and thromboxane A.sub.2 1993-02-02
5140031 Pyranyl cyanoguanidine derivatives Karnail Atwal, Kyoung S. Kim 1992-08-18
5116851 Pharmaceutical composition and method for treating cardiovascular diseases using substituted anilides and sulfonamides John Krapcho, James L. Bergey 1992-05-26
5066480 Method of preventing or reducing adverse reactions to protamine using a thromboxane A.sub.2 receptor antagonist Martin L. Ogletree, William A. Schumacher, Lawrence Friedhoff 1991-11-19
5011837 Aryl cyanoguanidines: potassium channel activators and method of making same Karnail Atwal, John Richard McCullough 1991-04-30
5008284 Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation James L. Bergey 1991-04-16
4975279 Method of improving post-ischemic myocardial function using a thromboxane A2 antagonist in combination with a thrombolytic agent and combination William A. Schumacher 1990-12-04
4962095 Method of reducing pre-and post-ischemic myocardial arrhythmias and fibrillation James L. Bergey 1990-10-09
4931460 Post-ischemic myocardial dysfunction using thromboxane A.sub.2 antagonists Irvin E. Fulmor, III 1990-06-05
4931464 Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation James L. Bergey 1990-06-05
4857548 Method of preventing or reducing platelet loss during extracorporeal circulation using a thromboxane A.sub.2 receptor antagonist 1989-08-15
4820733 Method of preventing or reducing platelet loss during extracorporeal circulation using a thromboxane A.sub.2 receptor antagonist 1989-04-11